abstract |
The invention relates to novel heterocyclic compounds which are pyrazolopyridine derivatives that induce fibroblast growth factor receptor (FGFR) dimerization, having the general formula: M 1 -L-M 2 in which M 1 or M 2 , which may be identical or different, each represent, independently of one another, a monomer unit M and L represents a linker group which links M 1 and M 2 covalently with the monomer unit which follows: Process for the preparation thereof and therapeutic use thereof. |